Welcome to Francis Academic Press

Academic Journal of Medicine & Health Sciences, 2023, 4(12); doi: 10.25236/AJMHS.2023.041203.

The Effect and Mechanism of Timosaponina-III from Anemarrhena Asphodeloides on Proliferation and Apoptosis of Human Liver Cancer Cell Line MHCC97H

Author(s)

Hao Zhao1, Xie Li2, Wu Yingying1

Corresponding Author:
Wu Yingying
Affiliation(s)

1Department of Oncology, The Second Naval Hospital of the Southern Theater Command of PLA, Sanya, China

2Department of Anesthesiology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, China

Abstract

To explore the effects and mechanism of TimosaponinA-III (Tim-AIII) on the proliferation and apoptosis of human liver cancer cells MHCC97H, an in vitro culture of MHCC97H cells was conducted. The logarithmic growth phase MHCC97H cells were divided into control group, Tim-AIII group, Tim-AIII + pc-DNA group, and Tim-AIII + pc-TGF-β1 group: the control group was MHCC97H cells, the Tim-AIII group was added with 40 nmol/L Tim-AIII, the Tim-AIII + pc-DNA group was transfected with blank control plasmid vector and added with 40 nmol/L Tim-AIII, and the Tim-AIII + pc-TGF-β1 group was transfected with TGF-β1 overexpression plasmid TGF-β1-OE and added with 40 nmol/L Tim-AIII. After culturing for 24 hours, the cloning formation experiment was used to detect the proliferation of each group of cells. Flow cytometry was used to detect the apoptosis rate of each group of cells. Western blot was used to detect the expression levels of TGF-β1 and ERK protein in each group of cells. The results showed that the numbers of clones in the control group, Tim-AIII group, Tim-AIII + pc-DNA group, and Tim-AIII + pc-TGF-β1 group were 221.69 ± 29.71, 32.18 ± 5.82, 31.92 ± 7.27, and 112.28 ± 23.42, respectively; the apoptosis rates were 13.60% ± 1.35%, 29.10% ± 2.71%, 30.00% ± 3.63%, and 21.70% ± 1.99%, respectively. Compared with the control group, the proliferation rate, clone number, and apoptosis rate of the Tim-AIII group and Tim-AIII + pc-DNA group were significantly different (P < 0.05); compared with the Tim-AIII group and Tim-AIII + pc-DNA group, the proliferation rate, clone number, and apoptosis rate of the Tim-AIII + pc-TGF-β1 group were significantly different (P < 0.05). Compared with the control group, the relative expression levels of TGF-β1 and ERK protein in the Tim-AIII group were significantly decreased (P < 0.05), while the relative expression levels of TGF-β1 and ERK protein in the pc-TGF-β1 group were significantly increased (P < 0.05); compared with the pc-TGF-β1 group, the relative expression levels of TGF-β1 and ERK protein in the Tim-AIII + pc-TGF-β1 group were significantly decreased (P < 0.05); compared with the Tim-AIII group, the relative expression levels of TGF-β1 and ERK protein in the Tim-AIII + pc-TGF-β1 group were significantly increased (P < 0.05). These results suggest that Tim-AIII can inhibit the proliferation of human liver cancer cells MHCC97H and promote apoptosis, which may be related to inhibiting the TGF-β1/ERK signaling pathway.

Keywords

Liver cancer; TimosaponinA-III; Proliferation; Apoptosis; TGF-β1/ERK

Cite This Paper

Hao Zhao, Xie Li, Wu Yingying. The Effect and Mechanism of Timosaponina-III from Anemarrhena Asphodeloides on Proliferation and Apoptosis of Human Liver Cancer Cell Line MHCC97H. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 12: 20-26. https://doi.org/10.25236/AJMHS.2023.041203.

References

[1] SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2020 [J]. CA Cancer J Clin, 2020, 70(1): 7-30.

[2] SIA D, VILLANUEVA A, FRIEDMAN S L, et al. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis [J]. Gastroenterology, 2017, 152(4): 745-761.

[3] WANG C, VEGNA S, JIN H, et al. Inducing and exploiting vulnerabilities for the treatment of liver cancer [J]. Nature, 2019, 574(7777): 268-272.

[4] WANG Y, DAN Y, YANG D, et al. The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacology [J]. J Ethnopharmacol, 2014, 153(1): 42-60.

[5] SONG X Y, HAN F Y, CHEN J J, et al. Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo [J]. Steroids, 2019, 146: 57-64.

[6] WEBERS A, HENEKA M T, GLEESON P A. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease [J]. Immunol Cell Biol, 2020, 98(1): 28-41.

[7] SY L K, YAN S C, LOK C N, et al. Timosaponin A-III induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells [J]. Cancer Res, 2008, 68(24): 10229-10237.

[8] WANG N, FENG Y, ZHU M, et al. A novel mechanism of XIAP degradation induced by timosaponin AIII in hepatocellular carcinoma [J]. Biochim Biophys Acta, 2013, 1833(12): 2890-2899.

[9] Yoojam S, Ontawong A, Lailerd N, Mengamphan K, Amornlerdpison D. The Enhancing Immune Response and Anti-Inflammatory Effects of Caulerpa lentillifera Extract in RAW 264.7 Cells. Molecules. 2021;26(19):5734. 

[10] Tang Z, Li G, Yang J, et al. Anemarrhena asphodeloides Non-Steroidal Saponin Components Alter the Pharmacokinetic Profile of Its Steroidal Saponins in Rat. Molecules. 2015;20(7):11777-11792. 

[11] Wang GJ, Lin LC, Chen CF, Cheng JS, Lo YK, Chou KJ, Lee KC, Liu CP, Wu YY, Su W, Chen WC, Jan CR. Effect of timosaponin A-III, from Anemarrhenae asphodeloides Bunge (Liliaceae), on calcium mobilization in vascular endothelial and smooth muscle cells and on vascular tension. Life Sci. 2002 Jul 19;71(9):1081-1090.

[12] HUANG H L, CHIANG W L, HSIAO P C, et al. Timosaponin AIII mediates caspase activation and induces apoptosis through JNK1/2 pathway in human promyelocytic leukemia cells [J]. Tumour Biol, 2015, 36(5): 3489-3497.

[13] CHEN J R, JIA X H, WANG H, et al. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway [J]. Int J Oncol, 2016, 48(5): 2063-2070.

[14] KANG Y J, CHUNG H J, NAM J W, et al. Cytotoxic and antineoplastic activity of timosaponin A-III for human colon cancer cells [J]. J Nat Prod, 2011, 74(4): 701-706.

[15] Katz LH, Likhter M, Jogunoori W, Belkin M, Ohshiro K, Mishra L. TGF-β signaling in liver and gastrointestinal cancers. Cancer Lett. 2016;379(2):166-172. doi:10.1016/j.canlet.2016.03.033

[16] CHEN W. TGF-beta Regulation of T Cells [J]. Annu Rev Immunol, 2023, 41: 483-512.

[17] MOREAU J M, VELEGRAKI M, BOLYARD C, et al. Transforming growth factor-beta1 in regulatory T cell biology [J]. Sci Immunol, 2022, 7(69): eabi4613.

[18] Zhang J, Zhu Y, Hu L, Yan F, Chen J. miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway. Sci Rep. 2019;9(1):7213. 

[19] Wu MZ, Yuan YC, Huang BY, et al. Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis Signal Transduct Target Ther. 2021;6(1):395.

[20] Ihling C, Naughton B, Zhang Y, et al. Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma. Front Med (Lausanne). 2019;6:15.

[21] WU L, YANG F, DU S, et al. Inorganic arsenic promotes apoptosis of human immortal keratinocytes through the TGF-beta1/ERK signaling pathway [J]. Environ Toxicol, 2022, 37(6): 1321-1331.

[22] HANGGI K, RUFFELL B. Cell death, therapeutics, and the immune response in cancer [J]. Trends Cancer, 2023, 9(5): 381-396.